Imidazolidinyl vanillic acid ether derivatives and their uses

Imidazolidinyl vanillic acid ether derivatives with structural modifications improve antiplatelet aggregation and bioavailability, effectively treating thrombotic diseases like myocardial infarction and stroke.

JP7883729B2Active Publication Date: 2026-07-02HEFEI INDUSTRIAL PHARMACEUTICAL INSTITUTE CO LTD +1
6 Cites 0 Cited by

Patent Information

Authority / Receiving Office
JP · JP
Patent Type
Patents
Current Assignee / Owner
HEFEI INDUSTRIAL PHARMACEUTICAL INSTITUTE CO LTD
Filing Date
2022-06-13
Publication Date
2026-07-02

Smart Images

  • Figure 0007883729000001
    Figure 0007883729000001
  • Figure 0007883729000002
    Figure 0007883729000002
  • Figure 0007883729000003
    Figure 0007883729000003
Patent Text Reader

Abstract

The present invention provides an imidazolidinyl vanillic acid ether derivative represented by formula (I) and its use. The imidazolidinyl vanillic acid ether derivative of formula (I) according to the present invention has higher in vivo bioavailability and in vivo antiplatelet aggregation activity compared to the prior art, and is useful for the treatment and / or prevention of thromboembolic-related diseases. 【Chemical 1】 JPEG2025518969000037.jpg31170
Need to check novelty before this filing date? Find Prior Art